Methotrexate

Achieving remission in psoriatic arthritis by early initiation of TNF inhibition: a double-blind, randomised, placebo-controlled trial of golimumab plus methotrexate versus placebo plus methotrexate
Leonieke J J van Mens, Henriëtte M de Jong, Inka Fluri, Michael T Nurmohamed, Marleen G H van de Sande, Marc Kok, Arno W R van Kuijk, Dominique Baeten

Annals of the Rheumatic Diseases May 2019, 78 (5) 610-616; DOI: 10.1136/annrheumdis-2018-214746
Optimal time between the last methotrexate administration and seasonal influenza vaccination in rheumatoid arthritis: post hoc analysis of a randomised clinical trial
Jin Kyun Park, Yunhee Choi, Kevin L Winthrop, Yeong Wook Song, Eun Bong Lee

Annals of the Rheumatic Diseases Mar 2019, annrheumdis-2019-215187; DOI: 10.1136/annrheumdis-2019-215187
Differing contribution of methotrexate polyglutamates to adalimumab blood levels as compared with etanercept
Thierry Dervieux, Joel M Kremer, Michael E Weinblatt

Annals of the Rheumatic Diseases Mar 2019, annrheumdis-2018-214860; DOI: 10.1136/annrheumdis-2018-214860
Consensus-based recommendations for the management of juvenile localised scleroderma
Francesco Zulian, Roberta Culpo, Francesca Sperotto, Jordi Anton, Tadej Avcin, Eileen M Baildam, Christina Boros, Jeffrey Chaitow, Tamàs Constantin, Ozgur Kasapcopur, Sheila Knupp Feitosa de Oliveira, Clarissa A Pilkington, Ricardo Russo, Natasa Toplak, Annet van Royen, Claudia Saad Magalhães, Sebastiaan J Vastert, Nico M Wulffraat, Ivan Foeldvari

Annals of the Rheumatic Diseases Mar 2019, annrheumdis-2018-214697; DOI: 10.1136/annrheumdis-2018-214697
Interaction between B-cell activation factor and methotrexate impacts immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis
Jin Kyun Park, Ye Ji Lee, Samuel Bitoun, Kevin L Winthrop, Yunhee Choi, Eun Bong Lee, Xavier Mariette

Annals of the Rheumatic Diseases Feb 2019, 78 (2) 282-284; DOI: 10.1136/annrheumdis-2018-214025
Adding baseline protein biomarkers to clinical predictors does not enhance prediction of treatment response to a methotrexate strategy in early rheumatoid arthritis
Xavier M Teitsma, Johannes W G Jacobs, Pascal H P de Jong, Johanna M W Hazes, Angelique E A M Weel, Paco M J Welsing, Attila Pethö-Schramm, Michelle E A Borm, Jacob M van Laar, Johannes W J Bijlsma, Floris P J G Lafeber

Annals of the Rheumatic Diseases Jan 2019, 78 (1) 142-144; DOI: 10.1136/annrheumdis-2018-213767
How to treat patients with rheumatoid arthritis when methotrexate has failed? The use of a multiple propensity score to adjust for confounding by indication in observational studies
Sytske Anne Bergstra, Lai-Ling Winchow, Elizabeth Murphy, Arvind Chopra, Karen Salomon-Escoto, João Eurico Fonseca, Cornelia F Allaart, Robert B M Landewé

Annals of the Rheumatic Diseases Jan 2019, 78 (1) 25-30; DOI: 10.1136/annrheumdis-2018-213731
Response to: ‘Metering the METEOR in methotrexate failure: is propensity score a falling star?’ by Ahmed et al
Sytske Anne Bergstra, Cornelia F Allaart, Robert B M Landewé

Annals of the Rheumatic Diseases Nov 2018, annrheumdis-2018-214652; DOI: 10.1136/annrheumdis-2018-214652
Metering the METEOR in methotrexate failure: is propensity score a falling star?
Sakir Ahmed

Annals of the Rheumatic Diseases Nov 2018, annrheumdis-2018-214612; DOI: 10.1136/annrheumdis-2018-214612
Predictors of disease activity and structural progression after treatment with adalimumab plus methotrexate or continued methotrexate monotherapy in patients with early rheumatoid arthritis and suboptimal response to methotrexate
Josef S Smolen, Ronald F van Vollenhoven, Stefan Florentinus, Su Chen, Jessica L Suboticki, Arthur Kavanaugh

Annals of the Rheumatic Diseases Nov 2018, 77 (11) 1566-1572; DOI: 10.1136/annrheumdis-2018-213502

Main menu

Methotrexate

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Methotrexate

Pages